Scientific Advisory Board

Elcin Zan, M.D., is a dual board-certified radiologist specializing in Neuroradiology and Nuclear Medicine. She is the Chair of Nuclear Medicine at Cleveland Clinic. Dr. Zan focuses on exploring the full potential of radiopharmaceutical therapies in oncology to meaningfully improve patient outcomes in clinic and research.

Prof. Alex A. Adjei is an accomplished researcher in the field of experimental therapeutics and clinical drug development. He is a Professor of Oncology and a Professor of Pharmacology at the Mayo College of Medicine (Rochester, USA), as well as a consultant in Medical Oncology at Mayo Clinic.

Oliver Sartor, M.D., is a medical oncologist in the Division of Medical Oncology in the Department of Oncology at Mayo Clinic in Rochester, Minnesota. Dr. Sartor serves as chair of the Genitourinary Cancer Disease Group and director of Radiopharmaceutical Clinical Trials across the enterprise for Mayo Clinic Comprehensive Cancer Center. Dr. Sartor joined the staff of Mayo Clinic in April 2023.

Prof. Artiko is the Director of the Nuclear Medicine Centre at the Clinical Centre of Serbia, as well as Head of the Department for Specialist Studies in Nuclear Medicine, and President of the Serbian Nuclear Medicine Society.

Dr. Thomas Sander, Scientific Advisor and Co-Founder, is an expert in cheminformatics and the Head of Scientific Computing at Idorsia Pharmaceuticals Ltd in Allschwil, Switzerland. After finishing his PhD thesis in organic chemistry, Thomas joined a team at Roche in Basel in 1993 to develop software for drug discovery.

Professor Vladan Vuletić earned the Physics Diploma with highest honors from the Ludwig-Maximilians-Universität München in 1992, and a Ph.D. in Physics (summa cum laude) from the same institution under the supervision of Professor T.W. Haensch in 1997.

Dr. Ralph M. Wirtz is a leading international molecular biologist who is very successfully involved in various research and development projects, all of which improve and develop innovative technologies to combat oncological diseases and make them available for patients.